Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Development and validation of a multiplex real-time qPCR assay using GMP-grade reagents for leprosy diagnosis

Fernanda Saloum de Neves Manta, View ORCID ProfileThiago Jacomasso, View ORCID ProfileRita de Cássia Pontello Rampazzo, Suelen Justo Maria Moreira, Najua Zahra, View ORCID ProfileMarcelo Ribeiro-Alves, Marco Aurélio Krieger, View ORCID ProfileAlexandre Dias Tavares Costa, Milton Ozório Moraes
doi: https://doi.org/10.1101/2021.10.04.21264517
Fernanda Saloum de Neves Manta
1Laboratório de Hanseníase, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thiago Jacomasso
2Instituto de Biologia Molecular do Paraná, Fiocruz, Curitiba, Paraná, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thiago Jacomasso
Rita de Cássia Pontello Rampazzo
2Instituto de Biologia Molecular do Paraná, Fiocruz, Curitiba, Paraná, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rita de Cássia Pontello Rampazzo
Suelen Justo Maria Moreira
1Laboratório de Hanseníase, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Najua Zahra
2Instituto de Biologia Molecular do Paraná, Fiocruz, Curitiba, Paraná, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcelo Ribeiro-Alves
3Instituto Nacional de Infectologia Evandro Chagas-Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marcelo Ribeiro-Alves
Marco Aurélio Krieger
2Instituto de Biologia Molecular do Paraná, Fiocruz, Curitiba, Paraná, Brazil
4Instituto Carlos Chagas, Fundação Oswaldo Cruz/FIOCRUZ, Curitiba, PR, Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandre Dias Tavares Costa
2Instituto de Biologia Molecular do Paraná, Fiocruz, Curitiba, Paraná, Brazil
4Instituto Carlos Chagas, Fundação Oswaldo Cruz/FIOCRUZ, Curitiba, PR, Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexandre Dias Tavares Costa
  • For correspondence: alexandre.costa@fiocruz.br milton.moraes@fiocruz.br
Milton Ozório Moraes
1Laboratório de Hanseníase, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alexandre.costa@fiocruz.br milton.moraes@fiocruz.br
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Leprosy is a chronic dermato-neurological disease caused by Mycobacterium leprae, an obligate intracellular bacterium. Timely detection is a challenge in leprosy diagnosis, relying on clinical examination and trained health professionals. Furthermore, adequate care and transmission control depend on early and reliable pathogen detection. Here, we describe a qPCR test for routine diagnosis of leprosy-suspected patients. The reaction simultaneously amplifies two specific Mycobacterium leprae targets (16S rRNA and RLEP), and the human 18S rRNA gene as internal control. The limit of detection was estimated to be 2.29 copies of M. leprae genome. Analytical specificity was evaluated using a panel of 20 other skin pathogenic microorganisms and Mycobacteria, showing no cross-reactivity. Intra- and inter-operator Cp variation was evaluated using dilution curves of M. leprae DNA or a synthetic gene, and no significant difference was observed between three operators in two different laboratories. The multiplex assay was evaluated using 97 patient samples with clinical and histopathological leprosy confirmation, displaying high diagnostic sensitivity (91%) and specificity (100%). Validation tests in an independent panel of 50 samples confirmed sensitivity and specificity of 97% and 98%, respectively. Importantly, assay performance remained stable for at least five months. Our results show that the newly developed multiplex qPCR effectively and specifically detects M. leprae DNA in skin samples, contributing to an efficient diagnosis that expedites the appropriate treatment.

Author Summary Leprosy is a chronic dermato-neurological disease caused by Mycobacterium leprae, an obligate intracellular bacterium. Disease diagnosis is currently performed on skin examinations for clinical signs, bacilli staining in skin smears and invasive skin biopsies. However, the spectrum of clinical manifestations and the low bacterial load can hinder accurate diagnosis, which is critical for providing proper intervention and adequate care as well as for establishing transmission control. Quantitative PCR (qPCR) methods for detecting bacterial DNA are more sensitive and could aid in differentially diagnosing leprosy from other dermatological conditions. In this work, we present a new multiplex qPCR that detects two bacterial genes for the diagnosis and a human gene as an internal reaction control. The new qPCR, developed using GMP-grade reagents, is highly sensitive, specific, reproducible, and stable. The results presented here are the basis of a novel and robust tool with potential to increase the accuracy of leprosy diagnosis in routine or reference laboratories.

Competing Interest Statement

Instituto de Biologia Molecular do Parana (IBMP) produces the PCR mastermix and some of the oligonucleotides used in the qPCR experiments. IBMP had no participation in the present study's design, data collection, analysis, interpretation, or writing of the report and decision to submit for publication.

Funding Statement

This work was funded by a grants from: Banco Nacional de Desenvolvimento Economico e Social (BNDES), contract no. 15.2.0473.1 (Operation #4.816.864) to MAK; and Novartis Foundation and Leprosy Research Initiative (LRI; 703.15.45), Foundation for Research Support of the State of Rio de Janeiro (FAPERJ;E-26/203.053/2016), Brazilian National Council for Scientific and Technological Development (CNPq 421852/2017-2018), Brazilian Coordination for Improvement of Higher Education Personnel (CAPES), and by the National Fund for Health/Brazilian Ministry of Health (MS/SCTIE/DECIT; 404277/2012-8 and TED 145/2018) to MOM.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Ethics Committee of the Oswaldo Cruz Foundation approved this study (CAAE: 38053314.2.0000.5248, number: 976.330; 10/03/2015).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Grant numbers and sources of support: This work was funded by a grants from: Banco Nacional de Desenvolvimento Econômico e Social (BNDES), contract no. 15.2.0473.1 (Operation #4.816.864) to MAK, and Novartis Foundation and Leprosy Research Initiative (LRI; 703.15.45), Foundation for Research Support of the State of Rio de Janeiro (FAPERJ;E-26/203.053/2016), Brazilian National Council for Scientific and Technological Development (CNPq; 421852/2017-2018), Brazilian Coordination for Improvement of Higher Education Personnel (CAPES), and by the National Fund for Health/Brazilian Ministry of Health (MS/SCTIE/DECIT; 404277/2012-8 and TED 145/2018) to MOM.

  • Disclosure of conflict of interest Instituto de Biologia Molecular do Paraná (IBMP) produces the PCR mastermix and some of the oligonucleotides used in the qPCR experiments. In addition, several authors received grants or fellowships from the Brazilian funding agencies CNPq and CAPES. This work was partially funded by grants from BNDES, Novartis Foundation, Leprosy Research Initiative, Foundation for Research Support of the State of Rio de Janeiro (FAPERJ), CNPq, CAPES, and by the National Fund for Health/Brazilian Ministry of Health (MS/SCTIE/DECIT). However, none of the aforementioned institutions had any participation in the present study’s design, data collection, analysis, interpretation, or writing of the report and decision to submit for publication.

Data Availability

All data is contained in the manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 05, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Development and validation of a multiplex real-time qPCR assay using GMP-grade reagents for leprosy diagnosis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Development and validation of a multiplex real-time qPCR assay using GMP-grade reagents for leprosy diagnosis
Fernanda Saloum de Neves Manta, Thiago Jacomasso, Rita de Cássia Pontello Rampazzo, Suelen Justo Maria Moreira, Najua Zahra, Marcelo Ribeiro-Alves, Marco Aurélio Krieger, Alexandre Dias Tavares Costa, Milton Ozório Moraes
medRxiv 2021.10.04.21264517; doi: https://doi.org/10.1101/2021.10.04.21264517
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Development and validation of a multiplex real-time qPCR assay using GMP-grade reagents for leprosy diagnosis
Fernanda Saloum de Neves Manta, Thiago Jacomasso, Rita de Cássia Pontello Rampazzo, Suelen Justo Maria Moreira, Najua Zahra, Marcelo Ribeiro-Alves, Marco Aurélio Krieger, Alexandre Dias Tavares Costa, Milton Ozório Moraes
medRxiv 2021.10.04.21264517; doi: https://doi.org/10.1101/2021.10.04.21264517

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (162)
  • Allergy and Immunology (416)
  • Anesthesia (91)
  • Cardiovascular Medicine (863)
  • Dentistry and Oral Medicine (159)
  • Dermatology (98)
  • Emergency Medicine (251)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8573)
  • Forensic Medicine (4)
  • Gastroenterology (388)
  • Genetic and Genomic Medicine (1759)
  • Geriatric Medicine (167)
  • Health Economics (373)
  • Health Informatics (1250)
  • Health Policy (622)
  • Health Systems and Quality Improvement (469)
  • Hematology (196)
  • HIV/AIDS (378)
  • Infectious Diseases (except HIV/AIDS) (10319)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (213)
  • Neurology (1682)
  • Nursing (97)
  • Nutrition (252)
  • Obstetrics and Gynecology (328)
  • Occupational and Environmental Health (451)
  • Oncology (930)
  • Ophthalmology (264)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (114)
  • Palliative Medicine (40)
  • Pathology (254)
  • Pediatrics (538)
  • Pharmacology and Therapeutics (254)
  • Primary Care Research (209)
  • Psychiatry and Clinical Psychology (1775)
  • Public and Global Health (3854)
  • Radiology and Imaging (626)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (521)
  • Rheumatology (208)
  • Sexual and Reproductive Health (168)
  • Sports Medicine (158)
  • Surgery (191)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)